New whooping cough strain in US raises questions

Northern, WI 02/07/2013 (wallstreetpr) – US Researchers have found traces of a vaccine resistant strain causing whooping cough in the country.

Health officials have taken this matter seriously and are investigating whether it might be one of the reasons why the U.S. just saw the worst year for whooping cough in the last six decades. The new strain of whooping cough virus was initially spotted in countries like Japan, France and Finland.

Whooping cough is a highly fatal disease that can attack people of any age group but children are more vulnerable to it. Once it was very common some years back, but cases in the U.S dropped ever since the vaccine was introduced in the 1940s.

There has been an incessant increment in the number of people down with whooping cough. An increase in the number of cases in the recent years, blames by degrees the version of the vaccine which has been in use since the 1990s, which doesn’t last long. According to a preliminary count, last year’s CDC reports filed 41,880 cases which included 18 death cases as well.

The new theories by researchers allege that the new whooping cough damage is the major reason why more people have been getting sick. The new bug was first found in France, where more rigorous and exhaustive testing is done regularly for whooping cough. The strain has now scored for 14% of cases there. A recent study in France also revealed that the existing vaccine protocol could only lower the risk infection  from the new strain in infants, by a small fraction.

Experts made a statement that in the United States doctors usually depend on a rapid and regular test to diagnose viral diseases And no clinical tests are conducted for identifying a new strain of virus.

For consideration of being featured on WallstreetPR, contact: Editor@Wallstreetpr.com

Please make sure to read and completely understand our disclaimer at https://www.wallstreetpr.com/disclaimer. FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. Any content posted on our website is for educational and informational purposes only and should NOT be construed as a securities-related offer or solicitation, or be relied upon as personalized investment advice. WallStreetPR strongly recommends you consult a licensed or registered professional before making any investment decision. Neither WallStreetPR.com nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization. WallStreetPR often gets compensated for advertisement services that are disclosed on our disclaimer located at WallStreetPR.com/Disclaimer.

Published by Fiona Gibson

Fiona is a finance graduate and an expert in analyzing market trends.